Allen R. Nissenson, MD, FACP

Industry Speaks III: IV Iron Therapy: A Practical Approach to Patient Management

UMX53-040

25th Annual Conference on Peritoneal Dialysis ~ 2005

  • Sale
  • Regular price $9.95


Treating the Iron Dextran Intolerant Patient - Chaim Charytan, MD

Determining the Optimal Maintenance Dose - Allen R. Nissenson, MD

Safety of IV Iron Agents - George R. Bailie, PharmD, PhD

Case Studies in IV Iron Agents - Joel D. Glickman, MD

Discussion

Adjourn